Suppr超能文献

相似文献

1
Paradoxical suppression of cellular senescence by p53.
Proc Natl Acad Sci U S A. 2010 May 25;107(21):9660-4. doi: 10.1073/pnas.1002298107. Epub 2010 May 10.
2
The choice between p53-induced senescence and quiescence is determined in part by the mTOR pathway.
Aging (Albany NY). 2010 Jun;2(6):344-52. doi: 10.18632/aging.100160.
3
Hypoxia suppresses conversion from proliferative arrest to cellular senescence.
Proc Natl Acad Sci U S A. 2012 Aug 14;109(33):13314-8. doi: 10.1073/pnas.1205690109. Epub 2012 Jul 30.
4
Weak p53 permits senescence during cell cycle arrest.
Cell Cycle. 2010 Nov 1;9(21):4323-7. doi: 10.4161/cc.9.21.13584. Epub 2010 Nov 10.
5
Decision-making by p53 and mTOR.
Aging (Albany NY). 2010 Jun;2(6):324-6. doi: 10.18632/aging.100166.
7
Elimination of proliferating cells unmasks the shift from senescence to quiescence caused by rapamycin.
PLoS One. 2011;6(10):e26126. doi: 10.1371/journal.pone.0026126. Epub 2011 Oct 11.
8
mTOR favors senescence over quiescence in p53-arrested cells.
Aging (Albany NY). 2010 Jun;2(6):327-8. doi: 10.18632/aging.100164.
9
Cooperation between p21 and Akt is required for p53-dependent cellular senescence.
Aging Cell. 2017 Oct;16(5):1094-1103. doi: 10.1111/acel.12639. Epub 2017 Jul 9.

引用本文的文献

1
Molecular Mechanisms of Cellular Senescence in Age-Related Endometrial Dysfunction.
Cells. 2025 Jun 6;14(12):858. doi: 10.3390/cells14120858.
3
Exploring the Genetic Orchestra of Cancer: The Interplay Between Oncogenes and Tumor-Suppressor Genes.
Cancers (Basel). 2025 Mar 24;17(7):1082. doi: 10.3390/cancers17071082.
4
Harnessing p53 for targeted cancer therapy: new advances and future directions.
Transcription. 2025 Feb;16(1):3-46. doi: 10.1080/21541264.2025.2452711. Epub 2025 Mar 3.
7
Understanding cellular senescence: pathways involved, therapeutics and longevity aiding.
Cell Cycle. 2023 Oct;22(20):2324-2345. doi: 10.1080/15384101.2023.2287929. Epub 2023 Dec 15.
8
c-Jun N-terminal kinase signaling in cellular senescence.
Arch Toxicol. 2023 Aug;97(8):2089-2109. doi: 10.1007/s00204-023-03540-1. Epub 2023 Jun 19.
9
Selective protection of normal cells from chemotherapy, while killing drug-resistant cancer cells.
Oncotarget. 2023 Mar 11;14:193-206. doi: 10.18632/oncotarget.28382.
10
Cellular senescence: when growth stimulation meets cell cycle arrest.
Aging (Albany NY). 2023 Feb 19;15(4):905-913. doi: 10.18632/aging.204543.

本文引用的文献

1
Sestrin as a feedback inhibitor of TOR that prevents age-related pathologies.
Science. 2010 Mar 5;327(5970):1223-8. doi: 10.1126/science.1182228.
3
Awakening guardian angels: drugging the p53 pathway.
Nat Rev Cancer. 2009 Dec;9(12):862-73. doi: 10.1038/nrc2763.
4
Cellular quiescence caused by the Mdm2 inhibitor nutlin-3A.
Cell Cycle. 2009 Nov 15;8(22):3777-81. doi: 10.4161/cc.8.22.10121. Epub 2009 Nov 23.
5
The first 30 years of p53: growing ever more complex.
Nat Rev Cancer. 2009 Oct;9(10):749-58. doi: 10.1038/nrc2723.
6
Pharmacologic p53 activation blocks cell cycle progression but fails to induce senescence in epithelial cancer cells.
Mol Cancer Res. 2009 Sep;7(9):1497-509. doi: 10.1158/1541-7786.MCR-09-0144. Epub 2009 Sep 8.
7
Regulation of protein synthesis by ionizing radiation.
Mol Cell Biol. 2009 Nov;29(21):5645-56. doi: 10.1128/MCB.00711-09. Epub 2009 Aug 24.
8
Pharmacologic inhibition of MEK and PI-3K converges on the mTOR/S6 pathway to decelerate cellular senescence.
Cell Cycle. 2009 Jun 15;8(12):1896-900. doi: 10.4161/cc.8.12.8809. Epub 2009 Jun 21.
9
Rapamycin decelerates cellular senescence.
Cell Cycle. 2009 Jun 15;8(12):1888-95. doi: 10.4161/cc.8.12.8606. Epub 2009 Jun 1.
10
Blinded by the Light: The Growing Complexity of p53.
Cell. 2009 May 1;137(3):413-31. doi: 10.1016/j.cell.2009.04.037.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验